PreveCeutical Medical Inc. (CSE:PREV)

PreveCeutical Medical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.01	0.06	0	0.01	0.02
Cash & Short-Term Investments	0.01	0.06	0	0.01	0.02
Cash Growth	-82.69%	4029.82%	-74.54%	-64.99%	-89.73%
Other Receivables	0.02	0.03	0.01	0.02	0.05
Receivables	0.02	0.03	0.01	0.02	0.05
Prepaid Expenses	0.06	0.03	0.06	0.04	0.01
Other Current Assets	0.99	-	-	-	-
Total Current Assets	1.08	0.12	0.06	0.06	0.08
Property, Plant & Equipment	0	0	0	0	0
Long-Term Investments	0.22	-	-	-	-
Other Intangible Assets	0.15	0.11	0.12	0.12	0.08
Total Assets	1.45	0.23	0.18	0.19	0.16
Accounts Payable	2.44	0.91	0.58	0.37	0.38
Accrued Expenses	-	1.49	1.49	1.16	0.95
Short-Term Debt	4.61	4.4	3.83	3.23	1.25
Current Portion of Long-Term Debt	0.07	-	0.06	0.06	-
Total Current Liabilities	7.12	6.8	5.96	4.82	2.59
Long-Term Debt	-	0.06	-	-	1.68
Other Long-Term Liabilities	0.57	-	-	-	-
Total Liabilities	7.69	6.86	5.96	4.82	4.27
Common Stock	21.22	19.59	19.31	19.31	18.56
Retained Earnings	-31.66	-29.56	-28.41	-27.26	-28.53
Comprehensive Income & Other	4.19	3.33	3.32	3.32	5.86
Shareholders' Equity	-6.24	-6.64	-5.78	-4.64	-4.1
Total Liabilities & Equity	1.45	0.23	0.18	0.19	0.16
Total Debt	4.68	4.46	3.89	3.29	2.93
Net Cash (Debt)	-4.67	-4.4	-3.89	-3.29	-2.91
Net Cash Per Share	-0.01	-0.01	-0.01	-0.01	-0.01
Filing Date Shares Outstanding	594.99	565.37	539.9	535.3	523.3
Total Common Shares Outstanding	594.99	543.7	535.3	535.3	511.7
Working Capital	-6.04	-6.68	-5.9	-4.76	-2.51
Book Value Per Share	-0.01	-0.01	-0.01	-0.01	-0.01
Tangible Book Value	-6.4	-6.74	-5.89	-4.76	-4.18
Tangible Book Value Per Share	-0.01	-0.01	-0.01	-0.01	-0.01
Machinery	-	0.02	0.02	0.02	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.